Cumberland Pharmaceuticals (CPIX) Short-term Investments (2012 - 2018)

Cumberland Pharmaceuticals (CPIX) has 7 years of Short-term Investments data on file, last reported at $8.3 million in Q4 2018.

• For the quarter ending Q4 2018, Short-term Investments rose 77.44% year-over-year to $8.3 million; the trailing twelve-month figure through Dec 2018 stood at $8.3 million (up 77.44% YoY), and the FY2018 full-year result was $8.3 million, up 77.44% from the prior year.
• Short-term Investments climbed to $8.3 million in Q4 2018, from $4.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $15.6 million in Q4 2016 to a low of $4.7 million in Q4 2017.
• A 5-year average of $11.6 million and a median of $14.6 million in 2015 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments tumbled 70.09% in 2017 and jumped 77.44% in 2018, its largest moves.
• Tracing CPIX's Short-term Investments over 5 years: stood at $14.8 million in 2014, then declined by 1.87% to $14.6 million in 2015, then climbed by 7.26% to $15.6 million in 2016, then plunged by 70.09% to $4.7 million in 2017, then soared by 77.44% to $8.3 million in 2018.
• Business Quant data shows CPIX's Short-term Investments at $8.3 million in Q4 2018, $4.7 million in Q4 2017, and $15.6 million in Q4 2016.